Matinas BioPharma Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leasehold Improvements and Equipment

Leasehold Improvements and Equipment

3 Months Ended

Mar. 31, 2021

Property, Plant and Equipment [Abstract]

Note 6 – Leasehold Improvements and Equipment

Leasehold improvements and equipment, summarized by major category, consist of the following as of March 31, 2021 and December 31, 2020:

	March 31, 2021		December 31, 2020
Lab equipment	$	1,443	$	1,443
Leasehold improvements		878		878
Total		2,321		2,321
Less: accumulated depreciation and amortization		856		797
Leasehold improvements and equipment, net	$	1,465	$	1,524

Depreciation and amortization expense for the three months ended March 31, 2021 and 2020 was approximately $59 thousand and $58 thousand, respectively.